Pulnovo Medical Company Profile 2024: Valuation, Funding & Investors | PitchBook
Pulnovo Medical Concludes Successfully the First Steering Committee Meeting - PR Newswire APAC
Pulnovo Medical - Raised $15.5M Funding from 8 investors - Tracxn
Pulnovo Medical | LinkedIn
Cynthia C. - Chairlady and Executive Vice President - Pulnovo Medical | LinkedIn
TCT2022| Pulnovo Medical Announced That The Latest Results Of PADN-CFDA Pivotal Trial Indicate Effectiveness And Safety of PADN For The Treatment Of Pulmonary Arterial Hypertension (PAH), Business News - AsiaOne
@MedTechStrat's video Tweet
Pulnovo Medical announces Dr M Zhang joins scientific advisory board - Medical Buyer
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval
pulnovomed,帕母医疗
Pulnovo Medical | LinkedIn
Presenting Companies | Innovation Summit Dublin 2024 — MedTech Strategist
Pulnovo Medical (帕母医疗) - Tech in Asia
Pulnovo's PADN Devices Approved in China and Receive FDA Humanitarian Use Designation - Endovascular Today
Pulnova Medical Archives - Cardiac Vascular News
Former FDA medical device officer joins Pulnovo Medical's scientific advisory board
Pulnovo Medical - Crunchbase Company Profile & Funding
Pulnovomed | Digital Health Corporate Profiles | HealthTech Alpha
帕母医疗
Pulnovo Medical will be attending JPM Healthcare Conference 2023_NewsRoom_pulnovomed,帕母医疗
Pulnovo Medical announces Dr M Zhang joins scientific advisory board - Medical Buyer
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval - Money Compass
